Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

A Pilot Study of Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy with Ex Vivo Generated Polyomavirus-Specific T-Cells

Irene Cortese, Austin John Barrett, David F. Stroncek, Steven Highfill, PhD, Erin Beck, Frances Andrada, Joan Ohayon, Jennifer Dwyer, Matthew Schindler, Georg Aue, Daniel Reich, Avindra Nath, Pawel Muranski, MD

Blood (2018) 132 (Supplement 1): 4535.

https://doi.org/10.1182/blood-2018-99-119832

Published: 2018

Journal Articles

Neoantigen Landscape of Relapsed Acute Leukemia Following Allogeneic Stem Cell Transplantation

Karolyn Oetjen, MD, Cai Chen, Christian Bradley, BS, Reema Panjwani, BS, Cheng Yan, Minoo Battiwalla, MD, Pawel Muranski, MD, Austin John Barrett, Sawa Ito, MD

Blood (2018) 132 (Supplement 1): 4595.

https://doi.org/10.1182/blood-2018-99-115501

Published: 2018

Journal Articles

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

Pawel Muranski, MD, Sarah I Davies, Sawa Ito, MD, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Quan Yu, Steven L Highfill, PhD, Marianna Sabatino, MD, David F. Stroncek, Minoo Battiwalla, MD, Austin John Barrett

Blood (2018) 132 (Supplement 1): 812.

https://doi.org/10.1182/blood-2018-99-119314

Published: 2018

Journal Articles

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Reema Panjwani, BS, Stefan Cordes, MD PhD, Zerick Terrell Dunbar, BS, MS, Jinguo Chen, MD, Prachi Jain, MD, Fariba Chinian, MS, Sara Hauffe, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Rongye Shi, MD, Huizhi Zhou, David Stroncek, MD, Nan Zhang, PhD, Sarah Davies, BS, Minoo Battiwalla, MD, Austin John Barrett, MD FRCP, FRCPath, Sawa Ito, MD

Blood (2017) 130 (Supplement 1): 4472.

https://doi.org/10.1182/blood.V130.Suppl_1.4472.4472

Published: 2017

Journal Articles

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Blood (2017) 130 (Supplement 1): 4516.

https://doi.org/10.1182/blood.V130.Suppl_1.4516.4516

Published: 2017

Journal Articles

Transplant biomarkers ready for the clinic?

Austin John Barrett

Blood (2017) 129 (2): 137–139.

https://doi.org/10.1182/blood-2016-11-751842

Published: 2017

Journal Articles

Adoptive T Cell Therapy for Polyomaviral Infections and Related Diseases

Dhana Chinnasamy, PhD, Greg Whitehill, BS, Keyvan Keyvanfar, BS, Isaac Brownell, MD PhD, Christopher Buck, PhD, Pawel Muranski, MD, Austin John Barrett, MDFRCP,FRCPath

Blood (2015) 126 (23): 4294.

https://doi.org/10.1182/blood.V126.23.4294.4294

Published: 2015

Journal Articles

Activity of the Telomerase Inhibitor GRN163L (Imetelstat) on Acute Myeloblastic Leukemia Blasts Is Enhanced By DNA Methyltransferase Inhibitors Irrespective of TERT Promoter Methylation Status

Caroline R Cantilena, BA, Xin Zhao, MD PhD, Sachiko Kajigaya, PhD, Neil Dunavin, MD, Xin Tian, PhD, Stephen A. Strickland, MD, Bipin N. Savani, MD, Sanjay R. Mohan, MD, Katayoun Rezvani, MDPhD, Xingmin Feng, PhD, Danielle M. Townsley, MD, Minoo Battiwalla, MDMS, Sawa Ito, MD, Austin John Barrett, MDFRCP,FRCPath

Blood (2015) 126 (23): 1267.

https://doi.org/10.1182/blood.V126.23.1267.1267

Published: 2015

Journal Articles

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

Dana L Shanis, MD, Prathima Anandi, MD, Caitlin Grant, Priyanka A Pophali, MD, Eleftheria Koklanaris, Bipin N. Savani, MD, Austin John Barrett, MDFRCP,FRCPath, Minoo Battiwalla, MD MS, Pamela Stratton, MD

Blood (2015) 126 (23): 1956.

https://doi.org/10.1182/blood.V126.23.1956.1956

Published: 2015

Journal Articles

Comparison of Donor KIR Genotype, Recipient CMV Reactivation and Pretransplant MRD in Predicting Relapse after Ex Vivo T-Deplete Allohsct

Robert Q. Le, MD PhD, Prathima Anandi, MD, Xin Tian, PhD, Sawa Ito, MD, Natasha A Jain, MD, Meghali Goswami, Catherine E. Lai, MD, Christopher S. Hourigan, MDPhD, Sharon Adams, Nancy F. Hensel, Austin John Barrett, MDFRCP,FRCPath, Minoo Battiwalla, MD MS

Blood (2015) 126 (23): 3212.

https://doi.org/10.1182/blood.V126.23.3212.3212

Published: 2015

Journal Articles

Selective Depletion of Alloreactive Donor T Cells with Adenosine: An Efficient, Scaleable, GMP-Compliant, Low-Cost Method to Prevent Gvhd While Preserving Antiviral and Antileukemic Activity in Haploidentical Stem Cell Transplant

Greg Whitehill, BS, Shoba Amarnath, BSc, MSc, PhD, Keyvan Keyvanfar, BS, Pawel Muranski, MD, Minoo Battiwalla, MDMS, Austin John Barrett, MDFRCP,FRCPath, Dhana Chinnasamy, PhD

Blood (2015) 126 (23): 380.

https://doi.org/10.1182/blood.V126.23.380.380

Published: 2015

Journal Articles

High Frequency of Circulating CD8 + Memory Stem T Cells in Acquired Aplastic Anemia

Kohei Hosokawa, MDPhD, Pawel Muranski, MD, Xingmin Feng, PhD, Danielle M. Townsley, MD, Baoying Liu, PhD, Jared Knickelbein, MD, Keyvan Keyvanfar, BS, Bogdan Dumitriu, MD, Sawa Ito, MD, Sachiko Kajigaya, PhD, James G. Taylor, MD, Mariana J. Kaplan, MD, Robert B. Nussenblatt, MD, Austin John Barrett, MDFRCP,FRCPath, John O'Shea, MD, Neal S. Young, MD

Blood (2015) 126 (23): 3613.

https://doi.org/10.1182/blood.V126.23.3613.3613

Published: 2015

Journal Articles

T Cell Depleted Allogeneic Stem Cell Transplants for Hematological Malignancies: A 20 Year Experience Shows No Relationship Between Choice of Transplanted T Cell Dose or Delayed T Cell Add-Back on Major Outcomes

Prathima Anandi, MD, Xin Tian, PhD, Puja D. Chokshi, Noelle Watters, Sawa Ito, Minoo Battiwalla, MD MS, Austin John Barrett, MDFRCP,FRCPath

Blood (2015) 126 (23): 2013.

https://doi.org/10.1182/blood.V126.23.2013.2013

Published: 2015

Journal Articles

A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Meghali Goswami, BS, Katherine S. McGowan, Kit Lu, MD, Natasha A Jain, MD, Julián Candia, PhD, Nancy F. Hensel, Jingrong Tang, MDPhD, Katherine R. Calvo, MD, PhD, Minoo Battiwalla, MDMS, Austin John Barrett, MDFRCP,FRCPath, Christopher S. Hourigan, MDPhD

Blood (2014) 124 (21): 667.

https://doi.org/10.1182/blood.V124.21.667.667

Published: 2014

NARROW

A Pilot Study of Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy with Ex Vivo Generated Polyomavirus-Specific T-Cells

Neoantigen Landscape of Relapsed Acute Leukemia Following Allogeneic Stem Cell Transplantation

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Complete Remissions Post Infusion of Multiple Tumor Antigen Specific T Cells for the Treatment of High Risk Leukemia and Lymphoma Patients after HCT

Transplant biomarkers ready for the clinic?

Adoptive T Cell Therapy for Polyomaviral Infections and Related Diseases

Activity of the Telomerase Inhibitor GRN163L (Imetelstat) on Acute Myeloblastic Leukemia Blasts Is Enhanced By DNA Methyltransferase Inhibitors Irrespective of TERT Promoter Methylation Status

Extensive Chronic Graft-Versus-Host-Disease Significantly Increases the Risk of Severe and Multifocal Genital Tract HPV Disease in Long-Term Survivors of Allogeneic Stem Cell Transplantation

Comparison of Donor KIR Genotype, Recipient CMV Reactivation and Pretransplant MRD in Predicting Relapse after Ex Vivo T-Deplete Allohsct

Selective Depletion of Alloreactive Donor T Cells with Adenosine: An Efficient, Scaleable, GMP-Compliant, Low-Cost Method to Prevent Gvhd While Preserving Antiviral and Antileukemic Activity in Haploidentical Stem Cell Transplant

High Frequency of Circulating CD8 + Memory Stem T Cells in Acquired Aplastic Anemia

T Cell Depleted Allogeneic Stem Cell Transplants for Hematological Malignancies: A 20 Year Experience Shows No Relationship Between Choice of Transplanted T Cell Dose or Delayed T Cell Add-Back on Major Outcomes

A Novel Multi-Gene Array Allows Relapse Risk Stratification in Acute Myeloid Leukemia Patients Undergoing Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only